ID WNT7A_HUMAN Reviewed; 349 AA. AC O00755; Q96H90; Q9Y560; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 17-APR-2007, sequence version 2. DT 25-JAN-2012, entry version 101. DE RecName: Full=Protein Wnt-7a; DE Flags: Precursor; GN Name=WNT7A; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Fetal brain; RX MEDLINE=97305141; PubMed=9161407; DOI=10.1016/S0378-1119(96)00808-6; RA Bui T.D., Lako M., Lejeune S., Curtis A.R.J., Strachan T., Lindsay S., RA Harris A.L.; RT "Isolation of a full-length human WNT7A gene implicated in limb RT development and cell transformation, and mapping to chromosome 3p25."; RL Gene 189:25-29(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=97049094; PubMed=8893824; RA Ikegawa S., Kumano Y., Okui K., Fujiwara T., Takahashi E., RA Nakamura Y.; RT "Isolation, characterization and chromosomal assignment of the human RT WNT7A gene."; RL Cytogenet. Cell Genet. 74:149-152(1996). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 204-327. RC TISSUE=Mammary gland; RX MEDLINE=94221588; PubMed=8168088; RA Huguet E.L., McMahon J.A., McMahon A.P., Bicknell R., Harris A.L.; RT "Differential expression of human Wnt genes 2, 3, 4, and 7B in human RT breast cell lines and normal and disease states of human breast RT tissue."; RL Cancer Res. 54:2615-2621(1994). RN [6] RP VARIANT FUHRS THR-109, VARIANT LPHAS CYS-292, CHARACTERIZATION OF RP VARIANT FUHRS THR-109, AND CHARACTERIZATION OF VARIANT LPHAS CYS-292. RX PubMed=16826533; DOI=10.1086/506332; RA Woods C.G., Stricker S., Seemann P., Stern R., Cox J., Sherridan E., RA Roberts E., Springell K., Scott S., Karbani G., Sharif S.M., RA Toomes C., Bond J., Kumar D., Al-Gazali L., Mundlos S.; RT "Mutations in WNT7A cause a range of limb malformations, including RT Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia RT syndrome."; RL Am. J. Hum. Genet. 79:402-408(2006). RN [7] RP VARIANT LPHAS CYS-292. RX PubMed=17431918; DOI=10.1002/ajmg.a.31712; RA Lonardo F., Sabba G., Luquetti D.V., Monica M.D., Scarano G.; RT "Al-Awadi/Raas-Rothschild syndrome: two new cases and review."; RL Am. J. Med. Genet. A 143:3169-3174(2007). RN [8] RP VARIANT LPHAS TRP-222. RX PubMed=20949531; DOI=10.1002/ajmg.a.33673; RA Kantaputra P.N., Mundlos S., Sripathomsawat W.; RT "A novel homozygous Arg222Trp missense mutation in WNT7A in two RT sisters with severe Al-Awadi/Raas-Rothschild/Schinzel phocomelia RT syndrome."; RL Am. J. Med. Genet. A 152:2832-2837(2010). RN [9] RP VARIANT LPHAS LYS-72. RX PubMed=21271649; DOI=10.1002/ajmg.a.33793; RA Garavelli L., Wischmeijer A., Rosato S., Gelmini C., Reverberi S., RA Sassi S., Ferrari A., Mari F., Zabel B., Lausch E., Unger S., RA Superti-Furga A.; RT "Al-Awadi-Raas-Rothschild (limb/pelvis/uterus-hypoplasia/aplasia) RT syndrome and WNT7A mutations: genetic homogeneity and nosological RT delineation."; RL Am. J. Med. Genet. A 155:332-336(2011). CC -!- FUNCTION: Ligand for members of the frizzled family of seven CC transmembrane receptors. Probable developmental protein. Signaling CC by Wnt-7a allows sexually dimorphic development of the mullerian CC ducts (By similarity). CC -!- SUBUNIT: Interacts with PORCN (By similarity). CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix. CC -!- TISSUE SPECIFICITY: Expression is restricted to placenta, kidney, CC testis, uterus, fetal lung, and fetal and adult brain. CC -!- DISEASE: Defects in WNT7A are the cause of limb pelvis hypoplasia CC aplasia syndrome (LPHAS) [MIM:276820]. A syndrome of severe CC deficiency of the extremities due to hypo- or aplasia of one or CC more long bones of one or more limbs. Pelvic manifestations CC include hip dislocation, hypoplastic iliac bone and aplastic pubic CC bones. Thoracic deformity, unusual facies and genitourinary CC anomalies can be present. CC -!- DISEASE: Defects in WNT7A are a cause of Fuhrmann syndrome (FUHRS) CC [MIM:228930]; also known as fibular aplasia or hypoplasia femoral CC bowing and poly- syn- and oligodactyly. Fuhrmann syndrome is a CC distinct limb-malformation disorder characterized also by various CC degrees of limb aplasia/hypoplasia and joint dysplasia. CC -!- SIMILARITY: Belongs to the Wnt family. CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/WNT7A"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U53476; AAC51319.1; -; mRNA. DR EMBL; D83175; BAA82509.1; -; mRNA. DR EMBL; CH471055; EAW64173.1; -; Genomic_DNA. DR EMBL; BC008811; AAH08811.1; -; mRNA. DR IPI; IPI00012990; -. DR RefSeq; NP_004616.2; NM_004625.3. DR UniGene; Hs.72290; -. DR ProteinModelPortal; O00755; -. DR IntAct; O00755; 1. DR MINT; MINT-1379349; -. DR STRING; O00755; -. DR PhosphoSite; O00755; -. DR PRIDE; O00755; -. DR Ensembl; ENST00000285018; ENSP00000285018; ENSG00000154764. DR GeneID; 7476; -. DR KEGG; hsa:7476; -. DR UCSC; uc003bye.1; human. DR CTD; 7476; -. DR GeneCards; GC03M013835; -. DR H-InvDB; HIX0003077; -. DR HGNC; HGNC:12786; WNT7A. DR HPA; CAB025894; -. DR HPA; HPA015719; -. DR MIM; 228930; phenotype. DR MIM; 276820; phenotype. DR MIM; 601570; gene. DR neXtProt; NX_O00755; -. DR Orphanet; 2854; Fuhrmann syndrome. DR Orphanet; 2879; Phocomelia, Schinzel type. DR PharmGKB; PA37387; -. DR eggNOG; prNOG10631; -. DR GeneTree; ENSGT00600000084153; -. DR HOGENOM; HBG446188; -. DR HOVERGEN; HBG001595; -. DR InParanoid; O00755; -. DR OMA; KTRRWIF; -. DR OrthoDB; EOG4GXFMZ; -. DR PhylomeDB; O00755; -. DR Reactome; REACT_111102; Signal Transduction. DR NextBio; 29284; -. DR ArrayExpress; O00755; -. DR Bgee; O00755; -. DR CleanEx; HS_WNT7A; -. DR Genevestigator; O00755; -. DR GermOnline; ENSG00000154764; Homo sapiens. DR GO; GO:0005615; C:extracellular space; IBA:RefGenome. DR GO; GO:0005886; C:plasma membrane; IBA:RefGenome. DR GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell. DR GO; GO:0005125; F:cytokine activity; IDA:BHF-UCL. DR GO; GO:0005109; F:frizzled binding; IBA:RefGenome. DR GO; GO:0048018; F:receptor agonist activity; IDA:BHF-UCL. DR GO; GO:0007257; P:activation of JUN kinase activity; IBA:RefGenome. DR GO; GO:0009952; P:anterior/posterior pattern specification; IBA:RefGenome. DR GO; GO:0060070; P:canonical Wnt receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0021846; P:cell proliferation in forebrain; IDA:BHF-UCL. DR GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB. DR GO; GO:0022009; P:central nervous system vasculogenesis; IBA:RefGenome. DR GO; GO:0021707; P:cerebellar granule cell differentiation; IBA:RefGenome. DR GO; GO:0009953; P:dorsal/ventral pattern formation; IBA:RefGenome. DR GO; GO:0000578; P:embryonic axis specification; IMP:BHF-UCL. DR GO; GO:0042733; P:embryonic digit morphogenesis; IMP:BHF-UCL. DR GO; GO:0035115; P:embryonic forelimb morphogenesis; IMP:BHF-UCL. DR GO; GO:0035116; P:embryonic hindlimb morphogenesis; IMP:BHF-UCL. DR GO; GO:0070307; P:lens fiber cell development; ISS:BHF-UCL. DR GO; GO:0050768; P:negative regulation of neurogenesis; IDA:BHF-UCL. DR GO; GO:0060021; P:palate development; IMP:BHF-UCL. DR GO; GO:0090263; P:positive regulation of canonical Wnt receptor signaling pathway; IBA:RefGenome. DR GO; GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IDA:BHF-UCL. DR GO; GO:0046330; P:positive regulation of JNK cascade; IBA:RefGenome. DR GO; GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL. DR GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL. DR GO; GO:0031133; P:regulation of axon diameter; IBA:RefGenome. DR GO; GO:0014719; P:satellite cell activation; IBA:RefGenome. DR GO; GO:0014834; P:satellite cell maintenance involved in skeletal muscle regeneration; IBA:RefGenome. DR GO; GO:0007548; P:sex differentiation; TAS:ProtInc. DR GO; GO:0035659; P:Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells; IDA:BHF-UCL. DR InterPro; IPR005817; Wnt. DR InterPro; IPR013300; Wnt7. DR InterPro; IPR018161; Wnt_grthfactor_CS. DR KO; K00572; -. DR PANTHER; PTHR12027; Wnt; 1. DR Pfam; PF00110; wnt; 1. DR PRINTS; PR01891; WNT7PROTEIN. DR PRINTS; PR01349; WNTPROTEIN. DR SMART; SM00097; WNT1; 1. DR PROSITE; PS00246; WNT1; 1. PE 1: Evidence at protein level; KW Complete proteome; Developmental protein; Disease mutation; KW Extracellular matrix; Glycoprotein; Reference proteome; Secreted; KW Signal; Wnt signaling pathway. FT SIGNAL 1 31 Potential. FT CHAIN 32 349 Protein Wnt-7a. FT /FTId=PRO_0000041442. FT CARBOHYD 83 83 N-linked (GlcNAc...) (Potential). FT CARBOHYD 127 127 N-linked (GlcNAc...) (Potential). FT CARBOHYD 295 295 N-linked (GlcNAc...) (Potential). FT VARIANT 72 72 E -> K (in LPHAS). FT /FTId=VAR_065765. FT VARIANT 109 109 A -> T (in FUHRS; retains activity that FT is significant but not comparable to FT wild-type activity). FT /FTId=VAR_030673. FT VARIANT 222 222 R -> W (in LPHAS). FT /FTId=VAR_064480. FT VARIANT 292 292 R -> C (in LPHAS; results in a loss of FT function mutation with some residual FT activity). FT /FTId=VAR_030674. FT CONFLICT 6 6 R -> L (in Ref. 1; AAC51319). FT CONFLICT 14 14 L -> F (in Ref. 2; BAA82509). FT CONFLICT 20 20 Y -> C (in Ref. 1; AAC51319). FT CONFLICT 35 35 S -> T (in Ref. 1; AAC51319). FT CONFLICT 103 104 EA -> DG (in Ref. 1; AAC51319). FT CONFLICT 125 125 Q -> H (in Ref. 1; AAC51319). FT CONFLICT 280 280 E -> G (in Ref. 5). FT CONFLICT 329 329 H -> Q (in Ref. 2; BAA82509). FT CONFLICT 338 338 T -> K (in Ref. 2; BAA82509). SQ SEQUENCE 349 AA; 39005 MW; 259EF506CFCD7AB0 CRC64; MNRKARRCLG HLFLSLGMVY LRIGGFSSVV ALGASIICNK IPGLAPRQRA ICQSRPDAII VIGEGSQMGL DECQFQFRNG RWNCSALGER TVFGKELKVG SREAAFTYAI IAAGVAHAIT AACTQGNLSD CGCDKEKQGQ YHRDEGWKWG GCSADIRYGI GFAKVFVDAR EIKQNARTLM NLHNNEAGRK ILEENMKLEC KCHGVSGSCT TKTCWTTLPQ FRELGYVLKD KYNEAVHVEP VRASRNKRPT FLKIKKPLSY RKPMDTDLVY IEKSPNYCEE DPVTGSVGTQ GRACNKTAPQ ASGCDLMCCG RGYNTHQYAR VWQCNCKFHW CCYVKCNTCS ERTEMYTCK //